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Lysosomes have traditionally been viewed as degra-
dative organelles, although a growing body of evi-
dence suggests that they can function asCa2+ stores.
Here we examined the function of these stores in hip-
pocampal pyramidal neurons. We found that back-
propagating action potentials (bpAPs) could elicit
Ca2+ release from lysosomes in the dendrites. This
Ca2+ release triggered the fusion of lysosomes with
the plasma membrane, resulting in the release of
Cathepsin B. Cathepsin B increased the activity of
matrix metalloproteinase 9 (MMP-9), an enzyme
involved in extracellular matrix (ECM) remodelling
and synaptic plasticity. Inhibition of either lysosomal
Ca2+ signaling or Cathepsin B release prevented the
maintenance of dendritic spine growth induced by
Hebbian activity. This impairment could be rescued
by exogenous application of active MMP-9. Our find-
ings suggest that activity-dependent exocytosis of
Cathepsin B from lysosomes regulates the long-
term structural plasticity of dendritic spines by trig-
gering MMP-9 activation and ECM remodelling.
INTRODUCTION
Lysosomes are classically viewed as degradative organelles
(Luzio et al., 2007b). Several studies, however, have demon-
strated that lysosomes, along with other related acidic organ-
elles, comprise additional sources of intracellular Ca2+. Notably,
these sources are distinct from the endoplasmic reticulum (ER)
and mitochondria (Galione, 2015). In this paper, we use the
term lysosome to collectively refer to the lysosome and its
related acidic organelles.
Ca2+ signaling from lysosomes has now been described in a
number of cell types (Galione et al., 2010, 2015). Ca2+ storage
in the lysosome requires an H+ gradient, which is generated by
a vacuolar H+-ATPase (V-ATPase), and some form of Ca2+/H+
exchange (Morgan et al., 2011). Ca2+ release from the lysosomes
requires the second messenger nicotinic acid adenine dinucleo-132 Neuron 93, 132–146, January 4, 2017 Crown Copyright ª 2017 P
This is an open access article under the CC BY license (http://creativetide phosphate (NAADP), which is synthesized, most likely by
ADP-ribosyl cyclases, in response to cell-specific physiological
stimuli (Galione et al., 2010, 2015). NAADP-dependent
Ca2+ efflux from lysosomes is thought to occur either via tran-
sient receptor potential cation channels of the mucolipin 1 family
(TRPML1) or via two-pore channels (TPC1/TPC2) (Guse, 2012),
with the weight of evidence currently suggesting that NAADP
acts via TPCs, most likely via an NAADP-associated binding pro-
tein (Morgan and Galione, 2014; Morgan et al., 2015b).
NAADP-dependent lysosomal Ca2+ signaling is likely to play a
role in neurons. NAADP binding sites have been found
throughout the brain (Patel et al., 2000), and NAADP synthesis
and lysosomal Ca2+ release in neurons can be triggered by exog-
enous stimulation with glutamate (Pandey et al., 2009). More-
over, application of NAADP elicits Ca2+ release in brain micro-
somes (Bak et al., 1999), promotes neuronal differentiation in
PC12 cells (Brailoiu et al., 2006), augments neurite outgrowth
in developing cortical neurons (Brailoiu et al., 2005), drives mem-
brane depolarization in medullary neurons (Brailoiu et al., 2009),
and increases Ca2+ influx through N-type voltage-gated
Ca2+ channels (VGCCs) in cultured hippocampal neurons (Hui
et al., 2015). Lysosomes have also been found in axonal bou-
tons, and pharmacologically inducedCa2+ release from these or-
ganelles can drive spontaneous neurotransmitter release (Brai-
loiu et al., 2003; McGuinness et al., 2007). Lysosomal
Ca2+ release, however, has not been investigated in postsyn-
aptic structures or in the context of synaptic plasticity.
In addition tomediating Ca2+ signaling, the lysosome itself can
also undergo Ca2+-dependent fusion, both with other organelles
and with the plasma membrane (Luzio et al., 2007b). In the latter
case, lysosomal exocytosis can be important in some cell types
for the secretion of chemical signals or enzymes (Blott and Grif-
fiths, 2002; Zhang et al., 2007; Galione et al., 2010; Davis et al.,
2012; Galione, 2015) or for promoting lipid turnover and facili-
tating membrane growth and repair (Reddy et al., 2001; Blott
and Griffiths, 2002; Luzio et al., 2007b). Although not well stud-
ied, lysosomal fusion has been reported in developing hippo-
campal and sympathetic neuronal cultures, where it regulates
the surface expression of N-type VGCCs and the outgrowth of
neurites, respectively (Arantes and Andrews, 2006; Hui et al.,
2015). However, it is not clear what physiological trigger drives
lysosomes to fuse with the plasmamembrane or the significance
of this fusion for information processing in neurons.ublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. Lysosomes Contribute to
bpAP-Evoked Dendritic Ca2+ Signaling
(A) Top: CA1 neuron loaded with Alexa 488 (green)
and stained with LysoTracker (red) (scale bar,
10 mm). Disruption of the lysosomal membrane
with GPN abolished LysoTracker staining. Regions
of interest (white boxes) aremagnified below (scale
bar, 2 mm).
(B) Average LysoTracker staining in ACSF (artificial
cerebrospinal fluid) andGPN (n = 5cells/condition).
Significance was assessed with a Mann-Whitney
test.
(C) Example bpAP-evoked Ca2+ transient in CA1
apical dendrites loaded with OGB-1 (scale bar,
10 mm). Laser scanning was restricted to a line
across a region of interest (circle). The resulting line
scan (scale bar, 50ms), alongwith its quantification
(%DF/F) is shown time-locked with electrophysio-
logical recordings. GPN reduced the bpAP-evoked
Ca2+ influx.
(D) CA1neuron loadedwithOGB-1.Ca2+ transients
evoked before (black traces) and after (red traces)
the addition of GPN are shown for regions of in-
terest (scale bar, 20 mm).
(E) Average data (n = 7–18 cells/condition).
Significancewas assessedwith Kruskal-Wallis and
post hoc Dunn’s tests. Error bars represent SEM.
See also Figures S1 and S2.Here we examined the role of lysosomes in hippocampal pyra-
midal neurons. We found that lysosomal Ca2+ signaling and lyso-
somal fusion with the plasma membrane were driven by back-
propagating action potentials (bpAPs) and were necessary for
the long-term structural plasticity of dendritic spines.
RESULTS
Lysosomes Contribute to bpAP-Evoked Dendritic
Ca2+ Signaling
We began by examining the distribution of lysosomes in hippo-
campal pyramidal neurons. To do so, we incubated hippocam-
pal slice cultures with LysoTracker red (50 nM, 40–60 min), a
fluorescent dye that preferentially labels lysosomal compart-
ments (Chazotte, 2011). We found LysoTracker-labeled punctathroughout the dendritic arbor of CA3
and CA1 neurons and in some dendritic
spines (Figure 1A). To confirm that Lyso-
Tracker fluorescence was specific for
lysosomes, we used glycyl-L-phenylala-
nine 2-naphthylamide (GPN, 200 mM,
5–10 min) to selectively disrupt lysosomal
compartments. GPN is a cell-permeable
substrate for the lysosome-specific
enzyme Cathepsin C. When cleaved,
GPN becomes membrane-impermeable
and exerts an osmotic effect that disrupts
the lysosomal membrane, leading to the
leakage of small molecules out of the
organelle (Penny et al., 2014). We found
that addition of GPN abolished the vastmajority of LysoTracker fluorescence in cells (n = 5 cells;
Mann-Whitney test, p < 0.01; Figure 1B), suggesting that
LysoTracker was predominantly labeling lysosomal compart-
ments. Notably, GPN-induced disruption of the lysosomal
membrane was not accompanied by any detrimental effects
on neuronal morphology (Figure 1A), resting membrane poten-
tial, conductance, and intracellular pH (Figures S1 and S2).
We next examined whether lysosomes contributed to den-
dritic Ca2+ signaling during neuronal activity. We loaded CA3
and CA1 neurons with the Ca2+-sensitive dye Oregon Green
BAPTA-1 (OGB-1) and imaged dendritic Ca2+ in response to
single bpAPs (Figure 1C). bpAP-evoked Ca2+ influx is thought
to be predominantly, if not exclusively, mediated by VGCCs
(Jaffe et al., 1992; Christie et al., 1995; Spruston et al., 1995;
Helmchen et al., 1996). However, we found that GPN, despiteNeuron 93, 132–146, January 4, 2017 133
Figure 2. Lysosomal Ca2+ Release Requires NAADP
(A–D) Left: sample Ca2+ transients evoked by single bpAPs in CA1 apical dendrites. Ca2+ transients were reduced following inhibition of lysosomal Ca2+ signaling
by various reagents. Right: average peak Ca2+ signal measured across conditions (n = 5–10 cells/condition). Significance was assessed withMann-Whitney tests
(single comparisons) or Kruskal-Wallis and post hoc Dunn’s tests (multiple comparisons).
(E) Left: example of line scan images (scale bar, 100 ms) and quantified traces (%DF/F) of Ca2+ signals recorded in CA1 apical dendrites in acute hippocampal
slices. Right: average peak fluorescence (n = 6–7 cells/condition). Ca2+ transients were reduced by GPN and NED-19. Significance was assessed with
Kruskal-Wallis and post hoc Dunn’s tests.
Error bars represent SEM. See also Figures S1–S5.having no effect on the action potential waveform (Fig-
ure S1), significantly reduced the Ca2+ rise evoked by a
single bpAP (in %DF/F; artificial cerebrospinal fluid [ACSF],
153 ± 11; GPN, 103 ± 10; n = 18 cells; post hoc Dunn’s
test, p < 0.01; Figures 1C–1E); these reductions were found
throughout the dendritic arbor (Figure 1D) and were also pre-
sent in acute hippocampal slices (n = 6 cells; post hoc Dunn’s
test, p < 0.05; Figures 2E and 2F). In contrast, application of
vehicle control (DMSO) alone had no effect on bpAP-evoked
Ca2+ transients (n = 7 cells; post hoc Dunn’s test, p = 0.99;
Figure 1E).134 Neuron 93, 132–146, January 4, 2017Lysosomal Ca2+ Release Requires NAADP
To confirm that neuronal activity could trigger Ca2+ release from
the lysosomes, we used additional means of pharmacologically
impairing lysosomal Ca2+ signaling (Galione, 2015; Morgan et al.,
2015a; Figure 8B).We started by specifically inhibiting lysosomal
Ca2+ storage, which requires a proton gradient to be established
by V-ATPases (Morgan et al., 2011). To disrupt this gradient, we
bath-applied the membrane-permeable Na+/H+ ionophore mon-
ensin (20 mM, 5–10 min). Monensin reduced the bpAP-evoked
Ca2+ transient (in %DF/F; ACSF, 179 ± 24; monensin,
100 ± 14; n = 6 cells; Mann-Whitney test, p < 0.05; Figure 2A)
despite having no effect on action potential waveform (Fig-
ure S1). However, as previously reported, application of monen-
sin resulted in membrane hyperpolarization (Figure S1), likely
related to a modest alkalization of intracellular pH (Figure S2;
Erecinska et al., 1991). Therefore, we conducted additional ex-
periments in which lysosomal Ca2+ storage was disrupted using
the V-ATPase inhibitor bafilomycin. Given the poor membrane
permeability of the drug, we pre-incubated slices with bafilomy-
cin (4 mM, 1–2 hr). This had no effect on the action potential
waveform or on the resting membrane potential (Figure S1) but
caused a significant decrease in the bpAP-associated
Ca2+ signal that was comparable in magnitude to the decrease
obtained in monensin (n = 6 cells/condition; bafilomycin versus
control; post hoc Dunn’s test, p < 0.05; Figure 2B). Notably, sub-
sequent addition of GPN resulted in no further reduction in the
Ca2+ signal (n = 6 cells; bafilomycin versusGPN, post hocDunn’s
test, p = 0.99; Figure 2B), suggesting that the effects of bafilomy-
cin were due to its inhibition of the proton gradient in lysosomes
as opposed to other organelles.
We next inhibited lysosomal Ca2+ release. Lysosomal
Ca2+ release requires NAADP, which most likely acts on TPCs
(Morgan et al., 2015b). Although low concentrations of NAADP
(10–100 nM) evoke Ca2+ efflux from the lysosome, higher con-
centrations (>100 mM) inhibit it via desensitization of the
Ca2+ release machinery (Berg et al., 2000; Masgrau et al.,
2003). Consistent with this, we found that a concentration of
1 mM NAADP in the patch electrode could inhibit lysosomal
Ca2+ release in hippocampal neurons (Figure S3). We also found
that this concentration of NAADP reduced the bpAP-evoked
Ca2+ signal (in %DF/F; ACSF, 158 ± 10; NAADP desensitization,
110 ± 11; n = 5 cells; post hoc Dunn’s test, p < 0.05; Figure 2C)
and occluded the effects of GPN (n = 5 cells; NAADP versus
GPN, post hoc Dunn’s test, p = 0.94; Figure 2C). Similar reduc-
tions in Ca2+ influx were also observed with the cell-permeable
NAADP antagonist NED-19 (100 mM, 30-to 60-min pre-incuba-
tion; n = 10 cells; Mann-Whitney test, p < 0.01; Figure 2D).
NED-19 also decreased the bpAP-associated Ca2+ signal in
acute hippocampal slices (n = 6 cells; post hoc Dunn’s test,
p < 0.05; Figure 2E), and, again, such reductions occluded the
effects of GPN (n = 6 cells; NED-19 versusGPN, post hoc Dunn’s
test, p = 0.48; Figure 2E).
Notably, drug-induceddecreases inbpAP-evokedCa2+ release
did not result from direct inhibition of VGCC currents (Figure S4)
or by affecting Ca2+ handling (Figure S5) but were likely due to in-
hibition of lysosomal Ca2+ signaling itself.
Ca2+ Influx through VGCCs Triggers Lysosomal
Ca2+ Release
Although NAADP is a necessary trigger for lysosomal
Ca2+ release, it alone does not explain how an electrical signal,
such as a bpAP, triggers Ca2+ release from the lysosome.We hy-
pothesized that an additional voltage-sensitive mechanism that
gates or modulates lysosomal Ca2+ release must be present.
One possibility is that the lysosomal Ca2+ release machinery
may be directly voltage-sensitive (Rybalchenko et al., 2012;
Cang et al., 2014; Pitt et al., 2014). Alternatively, lysosomes
may sense voltage indirectly via functional coupling with plasma
membrane voltage-gated channels. This coupling may be direct,as in the case of the mechanical coupling between ryanodine re-
ceptors and VGCCs in striated muscle (Sandow, 1952). This
coupling may also be indirect and mediated by a second
messenger such as Ca2+. Indeed, it is known that Ca2+ can
trigger NAADP-dependent lysosomal Ca2+ release (Patel et al.,
2001; Morgan et al., 2013), potentially by directly activating
TPCs (Pitt et al., 2010. 2014). Thus, it is possible that Ca2+ influx
from VGCCs during bpAPs may trigger Ca2+ release from
lysosomes.
To distinguish between these possibilities, we first attempted
to image lysosomal Ca2+ release in the presence of Ni2+ (100 mM)
and Cd2+ (100 mM) to inhibit VGCCs. This would determine
whether the lysosomes could release Ca2+ independent of
VGCC activity. Under these conditions, we could not detect
any Ca2+ transients, either in response to a single bpAP (n = 6
cells; post hoc Dunn’s test, p = 0.99; Figures 3A and 3B) or to
amore potent, 200-ms step depolarization to >20mV (n = 6 cells;
post hoc Dunn’s test, p = 0.99; Figures 3A and 3B) compared
with unstimulated controls (n = 6). These findings suggest that
membrane voltage alone cannot elicit lysosomal Ca2+ release
and that lysosomal Ca2+ signaling requires VGCC activation.
To examine specifically whether it was the direct mechanical
opening of VGCCs or VGCC-mediated Ca2+ influx that was trig-
gering lysosomal Ca2+ release, we repeated our experiments
in 0 Ca2+ ACSF, which prevents VGCC-mediated Ca2+ influx
but, unlike bath application of Ni2+ andCd2+, does sowithout po-
tential interference of the mechanical opening and closing of
VGCCs. Again, under these conditions, wewere unable to detect
any bpAP-evoked dendritic Ca2+ transients, either in response to
a single bpAP (n = 5 cells; post hoc Dunn’s test, p = 0.99; Fig-
ure 3B) or to a step depolarization to >20 mV (n = 5 cells; post
hoc Dunn’s test, p = 0.99; Figure 3B) compared with unstimu-
lated controls (n = 6). As a positive control, to ensure that our
experimental setup was sensitive enough to detect lysosomal
Ca2+ transients if present, we included low, physiologically rele-
vant concentrations of NAADP (10–100 nM) in our recording
electrode to directly trigger Ca2+ release from the lysosomes
(Calcraft et al., 2009; Figure S3). Under these conditions, we
could reliably detect small and rapid Ca2+ transients throughout
the dendritic arbor that could be abolished by the NAADP antag-
onist NED-19. Collectively, our findings suggest that Ca2+ influx
through VGCCs triggers lysosomal Ca2+ release. In this way,
lysosomal Ca2+ stores are indirectly coupled to VGCCs, enabling
them to be mobilized by changes in membrane voltage that
occur during bpAPs.
In many cell types, lysosomal Ca2+ release is functionally
coupled to Ca2+ release from the ER as opposed to VGCCs (Pa-
tel et al., 2001; Galione et al., 2010; Morgan and Galione, 2014).
Previous studies, however, have demonstrated that the ER does
not contribute to bpAP-evoked Ca2+ transients (Markram et al.,
1995; Emptage et al., 1999; Kovalchuk et al., 2000), arguing
against lysosome-ER coupling in neuronal dendrites. In line
with this, we found that blocking ER Ca2+ signaling with either
ryanodine (20 mM, 20 min) or thapsigargin (15 mM, 20 min) had
no effect on the amplitude of bpAP-evoked Ca2+ transients
(n = 5 cells/condition; Kruskal-Wallis test, p > 0.05; Figures 3C
and 3D). In a subset of experiments with thapsigargin, subse-
quent addition of GPN resulted in the expected reduction ofNeuron 93, 132–146, January 4, 2017 135
Figure 3. Ca2+ Influx through VGCCs
Triggers Lysosomal Ca2+ Release
(A) Example line scan images (scale bar, 100 ms)
and quantified traces (%DF/F) of bpAP-evoked
Ca2+ transients in CA1 apical dendrites (scale bar,
10 mm) time-locked to electrophysiological re-
cordings. Ni2+ and Cd2+ abolished Ca2+ influx
evoked either by a single bpAP or a 200-ms step
depolarization to >20 mV.
(B) Average data. Ca2+ transients were abolished
by inhibition of VGCC-mediated Ca2+ influx by
Ni2+/Cd2+ or 0 Ca2+ and did not significantly differ
from transients recorded in the absence of stimu-
lation (no stim. control) (n = 5–6 cells/condition).
(C) Sample bpAP-evoked Ca2+ transients shown
before and after the presence of ryanodine or
thapsigargin to inhibit Ca2+ signaling from the ER.
(D) AveragepeakCa2+ transients. Inhibition of ERor
mitochondrial Ca2+ signaling (FCCP) had no effect
on bpAP-evoked Ca2+ transients and failed to
occlude theeffects ofGPN (n= 3–5cells/condition).
Significance was assessed with paired t tests
(single paired comparisons) or Kruskal-Wallis and
post hocDunn’s tests (multiple comparisons). Error
bars represent SEM. See also Figure S3.bpAP-evoked Ca2+ signaling (n = 3 cells; paired t test, p < 0.05;
Figures 3C and 3D). Collectively, these findings suggest that the
ER is unlikely to play a role in bpAP-evoked lysosomal
Ca2+ release.
We also examined the possibility that lysosomal Ca2+ release
was coupled to mitochondrial Ca2+ stores. Consistent with a
previous report (Markram et al., 1995), application of the mito-
chondrial uncoupler FCCP (1 mM, 5 min) had no effect on
bpAP-evoked Ca2+ transients (n = 5 cells; Kruskal-Wallis test,
p > 0.05; Figure 3D) and failed to occlude the effects of GPN
(n = 5 cells; paired t test, p < 0.05; Figure 3D). These findings
suggest that, under our experimental conditions, the lysosome
is the only internal Ca2+ store that contributes to bpAP-evoked
Ca2+ signaling and is functionally coupled to VGCCs.
Lysosomal Ca2+ Signaling Drives Fusion of the
Lysosomes with the Plasma Membrane
What might be the function of lysosomal Ca2+ release in neu-
rons? The lysosome itself is known to undergo Ca2+-dependent
fusion both with other organelles andwith the plasmamembrane
(Luzio et al., 2007b). The source of Ca2+ in such instances can be136 Neuron 93, 132–146, January 4, 2017the lysosome itself (Pryor et al., 2000; Lu-
zio et al., 2007a, 2007b; Davis et al., 2012;
Galione, 2015). Lysosomal fusion to the
plasma membrane has been shown to
release chemical messengers or enzymes
in several cell types (Luzio et al., 2007b;
Galione, 2015). If present in neurons,
such a mechanism could have impli-
cations for activity-dependent process-
ing in dendrites. Additionally, our finding
of the strong functional coupling be-
tween VGCC activation and lysosomalCa2+ release in neurons suggests that lysosomes would be
ideally situated for activity-dependent fusion with the plasma
membrane, akin to synaptic vesicles in the presynaptic terminal.
We investigated whether activity-dependent release of
Ca2+ from the lysosome could trigger fusion of the lysosome to
the plasma membrane in neuronal dendrites. We started by
using total internal reflection fluorescence microscopy (TIRFM)
to monitor the dynamics of LysoTracker-stained lysosomes
near the plasma membrane in dissociated hippocampal cul-
tures. We found weak LysoTracker labeling in the dendrites un-
der baseline conditions (Figure 4A). However, when we elevated
extracellular K+ to 45mM to drive strong dendritic depolarization
and VGCC activity (Wu et al., 2001a, 2001b), we observed
a marked increase in the intensity of labeled puncta (Fig-
ure 4B) and an overall increase in surface fluorescence
(6.50%DF/F ± 0.05%DF/F; n = 5 cells; z test versus 0,
p < 0.01; Figure 4A; Movie S1). Depolarization had no such
effects on cells pre-incubated with NED-19, and, instead, only
decreases in fluorescence were observed because of the effects
ofphotobleaching (1.62%DF/F±0.76%DF/F;n=5cells;NED-19
versus K+, Mann-Whitney test, p < 0.05; Figures 4A and 4B).
Figure 4. Lysosomal Ca2+ Signaling Drives
Fusion of the Lysosomes with the Plasma
Membrane
(A) Top: TIRFM images of a dissociated hippo-
campal neuron loaded with LysoTracker. K+ stim-
ulation resulted in translocation of LysoTracker-
stained puncta to the cell surface (scale bar,
10 mm). The imaged area in the yellow box is
magnified below (scale bar, 5 mm). Bottom:
average change in LysoTracker fluorescence
across time (n = 5 cells/condition). K+-induced
increases in fluorescence were abolished by
NED-19. Time-dependent decreases in fluores-
cence reflected photobleaching. Significance was
assessed with Mann-Whitney test at the peak of
fluorescence.
(B) SampleTIRFMimagesof individual LysoTracker-
stainedpuncta in (A) (scale bar, 2mm).Graphsdepict
fluorescence intensity in AFU against time.
(C) Schematic of live-cell immunolabeling of
LAMP-2. Fluorescently tagged antibodies targeting
the lumenal domain of LAMP-2 were applied to
neuronal cultures during K+ stimulation. Fluorescent
labeling would require fusion of the lysosome with
the plasma membrane.
(D) Left: sample images depicting surface LAMP-2
antibody labeling in dissociated hippocampal
cultures (scale bar, 10 mm). Labeling in K+-treated
cultures was greater than under control conditions.
Right: the graph depicts group averages of LAMP-2
labeling (n = 10–23 cells/condition). NED-19 and
bafilomycinprevented activity-dependent increases
in LAMP-2 labeling.
Significance was assessed with Kruskal-Wallis and
post hoc Dunn’s tests. Error bars represent SEM.
See also Figure S6 and Movie S1.These findings suggest that membrane depolarization mobilized
lysosomesclose to thecell surfaceand in amannerdependent on
lysosomal Ca2+ signaling; however, from these data alone, we
could not determine whether such mobilization was followed by
fusion of the lysosome with the plasma membrane.
We next used live-cell immunolabeling in dissociated neurons
to examine whether lysosomes were capable of fusing with the
plasma membrane in an activity-dependent manner. We applied
a fluorescently labeled antibody targeting the lumenal domain of
the lysosome-associated membrane protein LAMP-2 during
K+-mediated depolarization. Under these conditions, fluores-
cent labeling of LAMP-2 would require lysosomes to fuse with
the plasma membrane (Figure 4C). Using this technique, we
found that membrane depolarization resulted in significantly
greater amounts of immunofluorescence in the dendrite
compared with control conditions (in arbitrary fluorescence units
[AFU]; K+, 35 ± 4; control, 24 ± 2; n = 23 cells/condition; post hoc
Dunn’s test, p < 0.05; Figure 4D). Knocking out LAMP-2 using
CRIPSR/Cas9 abolished all surface labeling, confirming that
immunofluorescence was specifically associated with LAMP-2
labeling (Figure S6). Moreover, pre-incubation of cells with either
NED-19 or bafilomycin abolished activity-induced increasesin LAMP-2 fluorescence (n = 10 cells; NED-19 versus
NED-19 + K+, post hoc Dunn’s test, p = 0.86;; n = 11 cells; bafi-
lomycin versus bafilomycin + K+, post hoc Dunn’s test, p = 0.93;
Figure 4D). These findings suggest that neuronal depolarization
drives lysosomal fusion with the plasma membrane and in a
manner dependent on activity-evoked lysosomal Ca2+ release.
To image lysosomal fusion with improved rapidity and sensi-
tivity, we made use of superecliptic pHlourin (SEP), a pH-sensi-
tive GFP that is commonly used as a probe for synaptic vesicle
fusion. We tagged SEP to the lumenal domain of LAMP-2 (Fig-
ure 5A). The fluorescence of LAMP2-SEP, which would be other-
wise quenched in the acidic environment of the lysosome,
should be detected upon exposure to the pH neutral environ-
ment of the extracellular fluid following lysosomal fusion with
the plasma membrane. We expressed LAMP2-SEP in dissoci-
ated cultures. LAMP2-SEP localized to lysosomes, retained
its pH sensitivity, and exhibited maximal fluorescence upon
de-acidification of the lysosome with NH4Cl (Figure S7). More-
over, upon K+ stimulation, we observed a large and rapid
increase in LAMP2-SEP fluorescence throughout the dendritic
arbor (68%DF/F ± 17%DF/F; n = 5 cells; versus baseline;
Mann-Whitney test, p < 0.05; Figures 5B–5D). This was followedNeuron 93, 132–146, January 4, 2017 137
Figure 5. Imaging Lysosomal Fusion with
LAMP2-SEP
(A) Schematic of LAMP2-SEP. pH-dependent
changes in fluorescence were used to monitor
lysosomal fusion.
(B) TIRFM image of a dissociated hippocampal
neuron transfected with LAMP2-SEP (scale bar,
10 mm). The imaged area in the yellow box is
magnified below (scale bar, 5 mm).
(C and D) Average K+-evoked changes in LAMP2-
SEPfluorescence in time (D, n=5–7cells/condition)
with peak changes quantified in (D). Activity-
dependent increases in fluorescence were abol-
ished by NED-19 or intracellular loading of Syt7.
(E) Schematic of the experiment using the alkaline
trap to examine lysosome fusion in response to
bpAPs. Neurons were stimulated with 300 action
potentials at 5 Hz in the presence of bafilomycin to
prevent re-acidification of the lysosome upon
internalization.
(F) Confocal image of a dissociated neuron trans-
fected with LAMP2-SEP (scale bar, 10 mm). The
imaged area in the yellow box is magnified below
(scale bar, 5 mm). bpAPs triggered an increase in
fluorescence.
(G) Average bpAP-evoked change in LAMP2-SEP
fluorescence (n = 6–7 cells/condition). No activity-
dependent increases in fluorescence occurred
following extracellular application of NED-19 or
intracellular loading of Syt7.
Significancewas assessed with Kruskal-Wallis and
post hoc Dunn’s tests. Error bars represent SEM.
See also Figure S7 and Movie S2.by a return to basal fluorescence within 65 s (n = 5 cells; fluores-
cence at 65 s versus baseline; Mann-Whitney test, p = 0.85; Fig-
ures 5B and 5C; Movie S2), likely reflecting the surface retrieval
and re-acidification of LAMP-2. Fusion of the lysosome with the
plasma membrane in several cell types has previously been
shown to require the actions of synaptotagmin 7 (Syt7) and
can be blocked by loading cells with the cytosolic domain of
Syt7 (Martinez et al., 2000; Luzio et al., 2007b). Therefore, to
confirm that increases in LAMP2-SEP fluorescence reflected
bona fide fusion of the lysosome with the plasma membrane,
we loaded cells with the cytosolic domain of recombinant
Syt7 (100 mg/mL). Under these conditions, we detected no in-
creases in fluorescence following K+ treatment (n = 5 cells;
Syt7 versus control, post hoc Dunn’s test, p < 0.05; Figures 5C
and 5D). Increases in fluorescence were also abolished by
NED-19 (n = 7 cells; versus control, post hoc Dunn’s test,
p < 0.05; Figures 5C and 5D), even when Ca2+ influx from VGCCs138 Neuron 93, 132–146, January 4, 2017was increased by elevating extracellular
Ca2+ from 2 mM to 4 mM and by adding
the voltage-gated K+ channel blocker
4-AP (100 mM) (n = 7 cells; NED-19 with
high Ca2+ versus control, post hoc Dunn’s
test, p < 0.05; Figures 5C and 5D). These
findings confirm that LAMP2-SEP can
detect fusion of lysosomes with the
plasma membrane and that Ca2+ releasefrom lysosomal stores is integral for the fusion of the lysosome
with the plasma membrane even when Ca2+ influx from VGCCs
is augmented.
LAMP2-SEP gave us the added advantage of examining
whether lysosome fusion could be triggered by dendritic depo-
larization evoked by bpAPs. Because we could not reliably
detect increases in LAMP2-SEP fluorescence to a single bpAP,
we made use of the alkaline trap method (Grubb and Burrone,
2009), which blocks vesicle re-acidification with the V-ATPase
inhibitor bafilomycin. This would enable fusion-mediated in-
creases in LAMP2-SEP fluorescence, if present, to accumulate
to measurable levels during repeated stimulation despite
LAMP-2 surface retrieval (Figure 5E). It is important to mention
that, although chronic incubation (>60 min) of bafilomycin in-
hibited lysosomal Ca2+ signaling (Figure 2B), acute applications
had no effect, likely because of the poor membrane permeability
of the drug. In keeping with this, brief application of bafilomycin
(<10 min) in the absence of any electrical stimulation produced
no change in LAMP2-SEP fluorescence (n = 6 cells; z test versus
0, p = 0.93; Figure 5G), suggesting that the drug alone had no ef-
fect on lysosomal pH. However, we did observe robust increases
in fluorescence when bafilomycin application was followed by
low-frequency (5-Hz) stimulation of 300 bpAPs, which was
achieved using field electrodes (27%DF/F ± 6%DF/F; n = 6 cells;
versus no stimulation; post hoc Dunn’s test, p < 0.01; Figures 5F
and 5G). No such increases were observed when stimulation
was delivered in the presence of NED-19 (n = 7 cells; versus
no stimulation; post hoc Dunn’s test, p = 0.99; Figure 5G) or
following intracellular loading of Syt7 (n = 5 cells; versus no stim-
ulation; post hoc Dunn’s test, p = 0.44; Figure 5G). Our findings
suggest that bpAP-evoked lysosomal Ca2+ release triggers
lysosomal fusion with the plasma membrane.
Lysosomal Fusion Results in the Release of Cathepsin B
The fusion of the lysosome with the plasma membrane likely
results in the release of its contents into the extracellular space.
We hypothesized that the release of lysosomal proteasesmay be
required for the activity-dependent restructuring of the extracel-
lular matrix (ECM). This would be of potential relevance for
long-term synaptic changes, which are known to require ECM
remodelling (Wlodarczyk et al., 2011; Dziembowska and Wlo-
darczyk, 2012). In this regard, Cathepsin B was of particular
interest to us. The cathepsins are a family of lysosomal proteases
that generally show preferential activation in acidic environ-
ments. Cathepsin B, however, exhibits enzymatic activity in
both acidic and pH-neutral environments, suggesting that,
upon lysosomal fusion, Cathepsin B would likely retain some
form of enzymatic activity in the pH-neutral extracellular space
(Mort et al., 1984; Linebaugh et al., 1999).
We first examined whether Cathepsin B could, in fact, be
released by neuronal lysosomes in an activity-dependent
manner. We incubated dissociated hippocampal neurons with
Magic Red Cathepsin B fluorogenic substrate, which fluoresces
upon Cathepsin B-mediated cleavage. Application of the sub-
strate resulted in labeling of fluorescent puncta that co-localized
with LysoTracker, confirming that active Cathepsin B was ubiq-
uitously present in neuronal lysosomes (Figure 6A; Figure S8).
Magic Red fluorescence also co-localized with Cathepsin
B-GFP fluorescence, confirming that it was labeling Cathepsin-
B containing compartments (Figure S8). We then stimulated cul-
tures with 45 mM K+ and found that this resulted in a loss of
Magic Red fluorescence in some of the imaged puncta, consis-
tent with the notion of lysosomal exocytosis, and the loss of
Cathepsin B activity from these sites (Figure 6A). A similar loss
of fluorescence was seen with LysoTracker (Figure 6A; Fig-
ure S8). The average loss of Magic Red fluorescence across
puncta (15.6%DF/F ± 1.6%DF/F; n = 226 puncta from 6 cells;
Figure 6B) was significantly greater than in unstimulated cultures
(n = 254 puncta from 5 cells; post hoc Dunn’s test, p < 0.01; Fig-
ure 6B), and in cultures pre-treated with NED-19 (n = 152 puncta
from 5 cells; post hoc Dunn’s test, p < 0.01; Figure 6B). We
defined puncta undergoing fusion as those exhibiting a loss of
Magic Red fluorescence of >3 SD from the average fluorescent
change measured in unstimulated control experiments. Using
this metric, we found that, with K+ stimulation, the fraction ofCathepsin B puncta undergoing fusion (8.4% ± 1.8%; n = 226
puncta from 6 cells; Figure 6C) was significantly greater than
that found in unstimulated controls (n = 254 puncta from 5 cells;
corrected z test, p < 0.01; Figure 6C) or in cultures pre-treated
with NED-19 (n = 152 puncta from 5 cells; versus K+ stimulation;
corrected z test, p < 0.01; Figure 6C). Live-cell immunolabeling of
synapses with anti-GluA1 antibodies additionally revealed that
>95% of Cathepsin B puncta, both the total pool of puncta
and those undergoing activity-dependent fusion, were located
within 1 mm of a GluA1-labeled punctum (Figure S8), suggesting
that Cathepsin B release occurs in the vicinity of synapses.
Cathepsin B Release Activates MMP-9
ECM remodelling is canonically associated with matrix metallo-
proteinases (MMPs). One means by which Cathepsin B can pro-
mote ECM remodelling is by recruiting MMP activity. It does so
by cleaving TIMP-1, an endogenous and potent inhibitor of
MMP signaling (Kostoulas et al., 1999; Murphy and Lynch,
2012). We therefore examined whether activity-dependent
release of lysosomal Cathepsin B could contribute to ECM re-
modeling in cultured hippocampal slices. Using an ELISA, we
first confirmed whether we could detect activity-dependent ele-
vations of Cathepsin B in the extracellular fluid. Similar to our
findings in dissociated neurons, we found that K+ treatment
elevated extracellular Cathepsin B in hippocampal slices (in
a.u.; control,0.19 ± 0.011; n = 8 slices; K+, 0.31 ± 0.006; n = 5 sli-
ces; post hoc Bonferroni test, p < 0.01; Figure 6D). Pre-treatment
with NED-19 greatly reduced this activity-dependent increase
(n = 7 slices; NED-19 + K+ versus K+; post hoc Bonferroni test,
p < 0.01; Figure 6D), although it did not quite abolish it (n = 7
and 5 slices; NED-19 versus NED-19 + K+; post hoc Bonferroni
test, p < 0.05, Figure 6D). We next examined whether extracel-
lular Cathepsin B was enzymatically active. To do so, we incu-
bated slices with a Cathepsin B fluorogenic substrate
(Z-Arg-Arg-AMC) and monitored increases in extracellular fluo-
rescenceasa readout of enzymatic activity (Figure 6E).Cathepsin
B activity was minimal under control conditions (77 ± 502 AFU;
n = 5 slices; z test versus 0, p = 0.87; Figure 6E), greatly enhanced
after K+ stimulation (1,717 ± 850 AFU; n = 5 slices; K+ versus con-
trol; posthocBonferroni test, p<0.05;Figure6E), andabolishedby
NED-19 (n = 5 slices/condition; NED-19 versusNED-19 + K+; post
hoc Bonferroni test, p = 0.99; Figure 6E). Collectively, these find-
ings are consistent with the activity-dependent release of active
Cathepsin B from lysosomal stores.
Cathepsin B is able to activate MMP signaling by cleaving the
MMP inhibitor TIMP-1 (Kostoulas et al., 1999; Murphy and
Lynch, 2012). We therefore examined whether activity-depen-
dent release of lysosomal Cathepsin B could mediate an in-
crease in extracellular MMP activity in hippocampal tissue. To
examine this, we incubated hippocampal slices with a broadly
selectiveMMP fluorogenic substrate (PEPDAB0502), which fluo-
resces upon MMP-mediated cleavage (Miller et al., 2011). We
examined MMP-associated fluorescence either in the presence
or absence of themembrane-impermeable Cathepsin B inhibitor
CA-074 (1 mM), which we used to selectively inhibit extracellular
Cathepsin B activity (Linebaugh et al., 1999; Mitrovic et al.,
2016). Notably, we saw no effect of CA-074 on MMP activity un-
der basal conditions (in AFU; control, 2,083 ± 207; n = 29 slices;Neuron 93, 132–146, January 4, 2017 139
Figure 6. Lysosomal Fusion Results in the Release of Cathepsin B, which Activates MMP-9 Signaling
(A) Confocal image of a dissociated hippocampal neuron (scale bar, 10 mm) loaded with Magic Red Cathepsin B fluorogenic substrate (red) and LysoTracker
(green). The dendrite in the white box is magnified below (scale bar, 5 mm) Cathepsin B-associated fluorescence co-localized with LysoTracker-labeled puncta
(yellow). Application of 45 mM K+ resulted in de-staining of some of the imaged puncta (yellow arrowheads), consistent with lysosomal fusion and loss of
Cathepsin B activity.
(B) Activity-dependent change in Cathepsin B-associated fluorescence of imaged puncta across experiments (n = 152–254 puncta from 5–6 cells/condition). The
dashed line marks 3 SD from average fluorescent changes recorded in unstimulated controls (no stim.). Significance was assessed with Kruskal-Wallis and post
hoc Dunn’s tests.
(C) Fraction of Cathepsin B puncta undergoing fusion, as defined by a fluorescence loss of >3 SD (dashed line in B). NED-19 prevented activity-dependent loss of
Cathepsin B activity. Significance was assessed with z tests (Bonferroni correction).
(D) Extracellular Cathepsin B expression levels in hippocampal slices measured using ELISA (n = 5–7 slices/condition). Activity was stimulated by elevating
extracellular K+ to 30 mM. Activity-dependent increases in Cathepsin B secretion were abolished with NED-19.
(legend continued on next page)
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CA-074, 1,601 ± 317; n = 15 slices; post hoc Bonferroni test,
p = 0.40; Figure 6F). However, given our finding that Cathepsin
B release is activity-dependent, we repeated the experiment
under high K+ conditions to promote Cathepsin B secretion
from lysosomal stores. Under these conditions we found that
MMP activity was significantly greater than that of controls
(AFU = 4,725 ± 259; n = 13 slices; K+ versus control; post hoc
Bonferroni test, p < 0.01; Figure 6F) and now sensitive to
Cathepsin B inhibition by CA-074 (AFU = 3,187 ± 317; n = 12
slices; CA-074 versus K+; post hoc Bonferroni test, p < 0.01; Fig-
ure 6F). These findings are consistent with the idea that activity-
dependent release of Cathepsin B stimulates MMP activity in
hippocampal slices.
Several studies have demonstrated that MMP-9, in particular,
is necessary for the maintenance of long-term potentiation (LTP)
and dendritic spine growth (Wang et al., 2008; Wlodarczyk
et al., 2011; Dziembowska and Wlodarczyk, 2012). We were
therefore interested in examining how Cathepsin B affected
MMP-9 activity in hippocampal slices. For this purpose, we
again incubated slices with the MMP fluorogenic substrate but
did so either in the presence or absence of an MMP-9 inhibitor
(100 nM MMP-9 inhibitor I). We took the reduction in
MMP-associated fluorescence that occurred in the presence
of the inhibitor as a readout of the levels of MMP-9 activity pre-
sent under a particular condition. Under control conditions, we
detected a small but significant level of MMP-9 activity
(AFU = 635 ± 220; n = 14 slices; z test, p < 0.01; Figure 6G).
Given that MMP-9 activation is driven by neuronal activity and
not normally detectable under baseline conditions (Nagy et al.,
2006; Dziembowska et al., 2012), we reasoned that the MMP-
9 activity in our experiment was likely driven by spontaneous
neuronal activity in our slices. Indeed, we found that MMP-9 ac-
tivity was abolished in the presence of TTX (n = 9 slices; z test
versus 0, p > 0.05; Figure 6G), although this did not reach sig-
nificance compared with control levels of activity (post hoc Bon-
ferroni test, p = 0.21). Conversely, elevating neuronal activity by
K+ stimulation greatly enhanced MMP-9 activity from control
levels (AFU = 2,592 ± 439; n = 10 slices; K+ versus control;
post hoc Bonferroni test, p < 0.01; Figure 6G). Given that
K+ stimulation also enhances Cathepsin B release, we asked
whether activity-dependent release of Cathepsin B was neces-
sary for the activity-dependent increase in MMP-9 activity. We
found that addition of either CA-074, to inhibit extracellular
Cathepsin B, or NED-19, to prevent activity-dependent
Cathepsin B release, abolished MMP-9 activity in K+ stimulated
slices (CA-074, n = 11 slices; versus K+; post hoc Bonferroni
test, p < 0.01; NED-19, n = 5 slices; post hoc Bonferroni test,
versus K+, p < 0.01; Figure 6G). Therefore, activity-dependent
increase of MMP-9 activity in hippocampal slices requires activ-
ity-dependent release of Cathepsin B.(E) Extracellular Cathepsin B activity levels measured in hippocampal slices using
Activity-dependent increases in Cathepsin B activity were abolished by NED-19
(F) Average MMP activity in hippocampal slices measured using an MMP fluorog
reduced MMP signaling in an activity-dependent manner.
(G) Average MMP-9 fluorogenic activity in hippocampal slices (n = 5–14 slices/con
and abolished by NED-19 and CA-074. Significance was assessed with ANOVA
Error bars represent SEM. See also Figures S8 and S9.MMP-9 and its endogenous inhibitor TIMP-1 co-localize to
secretory vesicles and are co-released with neuronal activity
(Nagy et al., 2006; Sbai et al., 2008; Dziembowska et al., 2012).
MMP-9 activity, therefore, will not necessarily depend on the
absolute levels of MMP-9 in tissue but on the ratio of MMP-9
to TIMP-1. Therefore, to provide additional evidence that
Cathepsin B is capable of recruiting MMP-9 activity, we exam-
ined the MMP-9/TIMP-1 ratio in hippocampal slices. We
reasoned that this ratio should be increased by neuronal activity
and in a manner dependent on lysosomal Cathepsin B. In agree-
ment with this, western blot analysis showed a marked increase
in the MMP-9/TIMP-1 ratio in slices treated with K+ (Figure S9).
Inhibiting Cathepsin B release with NED-19 or Cathepsin B activ-
ity with CA-074 inhibited these increases (Figure S9).
Cathepsin B Release Is Necessary for MMP-9-Mediated
Long-Lasting Structural Plasticity
Long-lasting changes in synaptic function are thought to ulti-
mately require stable, structural changes in the pre- or post-syn-
aptic elements, with LTP induction being associated with long-
lasting expansion of the postsynaptic density and a stable
enlargement of the dendritic spine head. Such changes require
ECM remodelling by MMP-9 (Wang et al., 2008; Wlodarczyk
et al., 2011; Dziembowska and Wlodarczyk, 2012). Given that
lysosomal-mediated release of Cathepsin B provides a means
by which neuronal activity can trigger activation of MMP-9, we
hypothesized that the lysosome would play a pivotal role in the
maintenance of structural plasticity. We therefore examined
the effect that inhibiting lysosomal Ca2+ signaling and fusion
with NED-19 would have on structural enlargements of dendritic
spines induced by Hebbian pairing. For this purpose, we filled
CA1 neuronswith Alexa Fluor 488 dye to visualize spine structure
and induced LTP by pairing brief (1 ms) photolysis of caged
glutamate on a target spine with 3–5 bpAPs (Figure 7A). The pair-
ing was repeated 60 times at 5 Hz. This protocol produced a
rapid and long-lasting expansion of the target spine that was
present at 1 min following stimulation (foldD = 1.75 ± 0.12;
n = 9 cells; z test versus 1.00, p < 0.01; Figures 7B and 7E)
and remained stable for at least 60 min thereafter (n = 9 cells;
foldD at 60min versus 1min;Mann-Whitney, p = 0.61; Figure 7B).
No enlargements were observed at neighboring spines (n = 9
cells; z test versus 1.00, p = 0.37; Figures 7B and 7E). Remark-
ably, NED-19 abolished long-lasting changes in structural
growth (n = 6 cells; foldD at 60 min; z test versus 1.00,
p = 0.78; Figures 7B and 7E) despite having no effect on the initial
spine growth recorded 1 min after paired stimulation (n = 6 cells;
versus control; Kruskal-Wallis, p = 0.29; Figures 7B and 7E);
similar results were obtained when lysosomal Ca2+ release was
instead inhibited with desensitizing concentrations of NAADP
in the recording electrode (n = 6 cells; foldD at 1 min versusthe fluorogenic Cathepsin B substrate Z-Arg-Arg-AMC (n = 5 slices/condition).
.
enic substrate (n = 12–29 slices/condition). Cathepsin B inhibition with CA-074
dition; Experimental Procedures). MMP-9 activity was driven by K+ stimulation
and post hoc Bonferroni tests.
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Figure 7. Cathepsin B Release Is Necessary for MMP-9-Mediated Long-Lasting Structural Plasticity
(A) Schematic of the experiment. Glutamate photolysis at a target spine was paired with bpAPs to induce long-lasting structural plasticity.
(B–D) Left: sample images of CA1 dendritic spines (scale bars, 1 mm). Images of target (yellow arrow) and neighboring spines are shown at 2.5, +1, +30,
and +60 min following paired stimulation. Right: average change in spine volume of target and neighboring spines across time (n = 5–9 cells/condition).
Long-lasting structural plasticity was abolished by inhibiting lysosomal function with NED-19, desensitizing concentrations of NAADP, or intracellular loading of
Syt7 (B). Structural plasticity was also abolished by inhibiting Cathepsin B activity with CA-074 (C). Bath application of either active Cathepsin B (C) or active
MMP-9 (D) for 10 min after the start of paired stimulation rescued long-lasting structural plasticity. Neighboring spines remained unchanged across experimental
conditions.
(E) Average change in spine volume at 60 min post-pairing for target and neighboring spines (n = 5–9 cells/condition).
Significance was assessed with Kruskal-Wallis and post hoc Dunn’s tests. Asterisks denote the significant differences (p < 0.05) from control conditions. All other
comparisons with control groups are not significant. Error bars represent SEM.
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Figure 8. Proposed Model
(A) 1: bpAPs activate dendritic VGCCs. 2: VGCC-mediated Ca2+ influx triggers
Ca2+ release from the lysosome via an NAADP-sensitive channel. 3: lysosomal
Ca2+ release triggers fusion of the lysosome with the plasma membrane,
resulting in the release of Cathepsin B. 4: Cathepsin B cleaves TIMP-1,
releasing MMP-9 from inhibition. 5: MMP-9 activity maintains the long-lasting
structural plasticity of dendritic spines.
(B) Targets of pharmacological reagents used in this study.control; Kruskal-Wallis, p = 0.29; foldD at 60 min, z test versus
1.00, p = 0.46; Figures 7B and 7E) or when lysosomal fusion
was inhibited with intracellular loading of the cytosolic domain
of Syt7 (n = 5 cells; foldD at 1 min versus control; Kruskal-Wallis,
p = 0.29; foldD at 60 min; z test versus 1.00, p = 0.46; Figures 7B
and 7E). These findings suggest that lysosomal Ca2+ release and
fusion are specifically involved in the maintenance, as opposed
to the induction, of structural plasticity; a very similar role has
been reported for MMP-9 (Wang et al., 2008). We hypothesized
that the reason why pharmacological impairment of lysosomal
function prevented structural plasticity was a failure of the post-
synaptic neuron to release Cathepsin B during neuronal activity.
Consistent with this idea, we found that inhibition of extracellular
Cathepsin B with CA-074, was able to phenocopy the effects of
NED-19 (n = 5 cells; foldD at 1 min; CA-074 versus NED-19; post
hoc Dunn’s test, p = 0.66; foldD at 60 min; CA-074 versus
NED-19; post hoc Dunn’s test, p = 0.99; Figures 7C and 7E),
whereas exogenous application of active Cathepsin B
(5 mg/mL applied for 10 min after the start of pairing) rescued
the NED-19 phenotype, restoring persistent expansion of the
target spine to control levels (foldD at 60 min = 1.87 ± 0.14;
n = 5 cells; versus control; post hoc Dunn’s test, p = 0.99; Figures
7C and 7E) without affecting neighboring spines (n = 5 cells;Kruskal-Wallis test, p = 0.72; Figures 7C and 7E). In contrast,
addition of active Cathepsin B in control experiments did not
further augment spine expansion (n = 5 cells; versus control;
post hoc Dunn’s test, p = 0.99; Figures 7C and 7E), suggesting
that Cathepsin B activity was not a limiting factor under normal
conditions of plasticity induction. To then test whether the func-
tion of lysosome fusion and Cathepsin B release, in the context
of structural plasticity, was to ultimately activate MMP-9, we at-
tempted to rescue the plasticity deficits induced by CA-074 and
NED-19 by exogenous application of active MMP-9 (5 mg/mL
applied for 10 min after the start of pairing). We found that
MMP-9 did indeed restore persistent expansion of the target
spine to control levels in both NED-19- and CA-074-treated sli-
ces (NED-19 +MMP-9, n = 5 cells; foldD at 60min versus control;
post hoc Dunn’s test, p = 0.99; CA-074 + MMP-9, n = 5 cells;
foldD at 60 min; versus control; post hoc Dunn’s test, p = 0.99;
Figures 7D and 7E) without affecting neighboring spines
(NED-19 + MMP-9, n = 5 cells; Kruskal-Wallis test, p = 0.72;
CA-074 + MMP-9, n = 5 cells; Kruskal-Wallis test, p = 0.72; Fig-
ures 7D and 7E). Notably, addition of activeMMP-9 in control ex-
periments did not further augment spine expansion (n = 5 cells;
foldD at 60 min versus control; post hoc Dunn’s test, p = 0.99;
Figures 7D and 7E), suggesting that the activity of MMP-9, like
that of Cathepsin B, was not a limiting factor under normal con-
ditions of plasticity induction.
DISCUSSION
Here we found that dendritic Ca2+ influx from VGCCs during
bpAPs triggered Ca2+ release from the lysosome. This
Ca2+ release led to the fusion of the lysosome with the plasma
membrane, resulting in the release of Cathepsin B and the sub-
sequent recruitment of MMP-9 activity. We found that activity-
dependent enhancement of MMP-9 signaling by Cathepsin
B was necessary for the maintenance of the long-lasting den-
dritic spine growth that accompanies Hebbian pairing of synap-
tic activity with postsynaptic bpAPs (Figure 8A).
Our finding that bpAPs can trigger Ca2+ release from the lyso-
some is unexpected because it has long been thought that
bpAP-evoked Ca2+ influx is mediated exclusively by VGCCs
with little or no contribution from intracellular stores. The evi-
dence for this comes from the fact that bpAP-evoked Ca2+ sig-
nals are essentially abolished following VGCC inhibition or
removal of extracellular Ca2+ (Jaffe et al., 1992; Christie et al.,
1995; Spruston et al., 1995; Helmchen et al., 1996), whereas in-
hibition of ER or mitochondrial Ca2+ signaling is without effect
(Markram et al., 1995; Emptage et al., 1999; Kovalchuk et al.,
2000). We found similar effects in our own study when blocking
VGCC-, ER-, and mitochondrion-mediated Ca2+ signaling; how-
ever, we were also able to unmask a role for lysosomal stores.
Notably, we found no evidence of lysosomal Ca2+ release under
conditions in which VGCC-mediated Ca2+ influx was inhibited,
suggesting that lysosomal Ca2+ release was likely triggered by
Ca2+ influx through VGCCs. Others have demonstrated that
Ca2+ from other sources, such as the ER, can trigger lysosomal
Ca2+ release (Patel et al., 2001; Morgan et al., 2013), potentially
by directly activating TPCs (Pitt et al., 2010, 2014); although the
exactmechanism remains unclear, it does suggest that TPCs areNeuron 93, 132–146, January 4, 2017 143
regulated both by Ca2+ and by NAADP. To the best of our knowl-
edge, we are the first to report evidence of a functional coupling
between VGCCs and lysosomes, which may potentially be a
feature unique to excitable tissue. Certainly, such a coupling is
an efficient means of endowing lysosomes with voltage sensi-
tivity, thereby enabling lysosomal Ca2+ release to be driven by
neuronal activity.
Although Ca2+ release from the lysosomes may serve a num-
ber of functions, in this study, we found that it drove the fusion of
lysosomes with the plasma membrane. Why Ca2+ release from
the lysosome, as opposed to other sources, is particularly impor-
tant for its fusion with the plasma membrane is not clear, but a
similar mechanism is thought to underlie lysosomal exocytosis
in other cell types (Davis et al., 2012; Galione, 2015) and sug-
gests that the lysosomal fusion machinery is sensitive to nano-
domain Ca2+ signaling generated locally by the organelle itself.
It is, however, important to note that, from out data alone,
we cannot determine whether the lysosomes releasing Ca2+ in
response to bpAPs are those that subsequently undergo fusion
with the plasma membrane; it is possible that distinct subpopu-
lations of lysosomes may differentially mediate these functions.
We found that fusion of the lysosomewas accompanied by the
release of Cathepsin B into the extracellular space. Cathepsin B
release has generally been reported in the context of patholog-
ical conditions. In neural tissue, excessive levels of extracellular
Cathepsin B release have been associated with cell death in
traumatic brain injury, brain aneurysm, and several neurologic
diseases such as aminotrophic lateral sclerosis (ALS),
Alzheimer’s disease, Parkinson’s disease, and Huntington’s dis-
ease (Pislar and Kos, 2014; Hook et al., 2015). Potential media-
tors of Cathepsin B release under these conditions include reac-
tive astrocytes, microglia, and/or macrophages (Ryan et al.,
1995; Linebaugh et al., 1999; Kingham and Pocock, 2001; Gan
et al., 2004; Murphy and Lynch, 2012). Although the exact mech-
anism by which these cells release Cathepsin B is not clear, if it
involves lysosomal fusion with the plasma membrane, as re-
ported in this study, then pharmacological inhibition of lysosomal
Ca2+ signaling may provide a novel means for preventing exces-
sive Cathepsin B release under pathological conditions.
We showed that Cathepsin B release was essential for the
maintenance of long-term structural plasticity, likely by recruiting
MMP-9 activity via cleavage of TIMP-1 (Kostoulas et al., 1999;
Murphy and Lynch, 2012). Although several studies have
demonstrated a role for MMP-9 in long-term synaptic plasticity,
the mechanism by which neuronal activity triggers an increase in
MMP-9 activity is not completely understood (Wlodarczyk et al.,
2011; Dziembowska and Wlodarczyk, 2012). In the context of
LTP, it is known that neuronal stimulation triggers the transport
and translation of MMP-9 mRNA in neuronal dendrites, followed
by MMP-9 release into the ECM (Nagy et al., 2006; Dziembow-
ska et al., 2012), where it is converted into its active form, likely
via plasmin-mediated cleavage of the MMP-9 pro-domain (Wlo-
darczyk et al., 2011). However, upon secretion, MMP-9 is com-
plexed with its inhibitor TIMP-1 (Sbai et al., 2008), which is
capable of inhibiting both active and inactive forms of MMP-9
(Ogata et al., 1995). Inhibition of TIMP-1 signaling, therefore, is
likely to be crucial for the maintenance of LTP. Based on our re-
sults, we would suggest that the activity-dependent secretion of144 Neuron 93, 132–146, January 4, 2017Cathepsin B from neuronal lysosomes is one possible means by
which TIMP-1 signaling can be inhibited (Figure 8).
Although traditionally viewed as the degradative compartment
of the cell, a growing body of evidence suggests that the lyso-
some functions as a Ca2+ store that is capable of mediating a
diverse array of physiological functions across numerous cell
types (Galione et al., 2010, 2015). In this study, we examined
the role of lysosomes in neurons. Our findings reveal that lyso-
somes mediate activity-dependent Ca2+ signaling in the den-
drites and, via the release of Cathepsin B, play an important
and unexpected role in the long-term maintenance of structural
plasticity.
EXPERIMENTAL PROCEDURES
Hippocampal Tissue Preparation
All animal work was carried out in accordance with the Animals (Scientific Pro-
cedures) Act, 1986 (UK) and under project and personal licenses approved by
the Home Office (UK). Acute coronal hippocampal slices (350–400 mm) were
prepared from male Wistar rats (post-natal day 14 [P14]–P21) and perfused
(3 mL/min) with ACSF (120 mM NaCl, 2.5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 1.2 mM NaH2PO4, 26 mM NaHCO3, 11 mM glucose, 0.2 mM ascorbic
acid, and 1 mM Trolox; pH = 7.2–7.4; 32C–34C; 95% O2 and 5% CO2).
Cultured hippocampal slices (350 mm) were prepared from male Wistar rats
(P7). Slices (days in vitro [DIV] 10–15) were perfused (1–2 mL/min) with heated
ACSF (32C–34C). For dissociated cultures, hippocampal cells from P1 male
Wistar rats were plated onto 18-mmcoverslips (3–63 104 cells/coverslip), pre-
coated with poly-D-lysine (0.1 mg/mL) and fibronectin (0.05 mg/mL), and
imaged on DIV 10–21 in Tyrode’s buffer (128 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 2 mM CaCl2, 4.2 mM NaHCO3, 20 mM glucose, and 15 mM HEPES;
pH = 7.2–7.4; 22C–24C). For K+ stimulation, 30 or 45 mMNaCl was replaced
with KCl. See Supplemental Experimental Procedures for further details.
Ca2+ Imaging and Electrophysiology
CA3 or CA1 cells in hippocampal slices were recorded using either sharp mi-
croelectrodes (70–120 MU) or high-resistance patch electrodes (16–25 MU) to
minimize intracellular dialysis. For Ca2+ imaging, sharp microelectrodes con-
tained 0.5–1 mM OGB-1 (Thermo Fisher Scientific) dissolved in 200–400 mM
potassium acetate. Patch electrodes contained OGB-1 (0.1–0.2 mM) dis-
solved in internal solution (135 mM KGluconate, 10 mM KCl, 10 mM HEPES,
2 mM MgCl2, 2 mM Na2ATP, and 0.4 mM Na3GTP; pH = 7.2–7.4). Apical den-
drites were imaged using confocal laser-scanning microscopy and a 488-nm
argon laser. bpAPs were triggered with somatic current injection (1–2 nA,
5–10 ms) and recorded with an AxocLAMP-2B amplifier (Axon Instruments).
See Supplemental Experimental Procedures for further details.
Cathepsin B and MMP Assays
Assays were done on slice culture supernatant using a plate reader. Cathepsin
B levels were assessed using a colorimetric human Cathepsin B ELISA kit
(ab119684, Abcam)according to the manufacturer’s instructions. Cathepsin
B and MMP activity was assessed by incubating slices either with the
Cathepsin B fluorogenic substrate Z-Arg-Arg-AMC (1:200, JA7740, Merck
Millipore) or a MMP fluorogenic substrate (5 mM PEPDAB0502, Biozyme) for
2 hr and examining fluorescence in the supernatant. MMP-9 activity levels
were calculated as the difference in MMP fluorescence obtained in the
absence and presence of an MMP-9 inhibitor (100 nM of MMP-9 inhibitor I).
See Supplemental Experimental Procedures for further details.
Structural Plasticity and Spine Imaging
CA1 cells in slice cultures were patched (16–25 MU) with KGluconate internal
solution containing Alexa Fluor 488 (0.1–0.2 mM, Thermo Fisher Scientific).
Small dendritic spines (<1 mm) were targeted for MNI-glutamate spot photol-
ysis using a 405-nm laser (Photonics). LTP was induced by pairing photolysis
(1 ms) with three to five action potentials. Pairing was repeated 60 times at
5 Hz. Fractional changes in fluorescence of the spine head, standardized to
that of the underlying dendrite, were used to estimate fractional changes in
spine volume. See Supplemental Experimental Procedures for further details.
Statistical Analysis
Significance was assessed using parametric tests (two-tailed paired and un-
paired t test) or non-parametric tests (two-tailed Mann-Whitney test or
two-tailed Wilcoxon matched-pairs test) in which a normal distribution of
data could not be confirmed. One-sample z tests were used for comparisons
against a known value. The Pearson correlation coefficient was used for as-
sessing the significance of linear trends. For multiple comparisons, ANOVA
and post hoc Bonferroni’s tests (parametric) or the Kruskal-Wallis test with
post hoc Dunn’s tests (non-parametric) were used. In the text, values are
quoted as mean ± SEM, and significance is quoted either at the p < 0.05 or
p < 0.01 level.
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